NVDA231.50+0.44% BTC/USD82,942.24+1.53% TSLA387.52+3.34% EUR/USD1.12-0.13% GOLD4,209.30+1.26% ISP.MI6.12+0.94% RACE.MI347.85+1.47% AAPL333.70-1.97% S&P 500 ETF777.06+0.40%
TradeGPT TradeGPT AI
Google Play Get App (Free)

Zoetis (ZTS)

Healthcare & Pharma • Quantitative Market Data & AI Analytics

RSI(14): 56.9 🔒 AI Forecast in App
74.12
+1.04 (+1.42%) 24h | +6.18% 7D | Latest Active Session
ZTS Interactive Historical Chart (1Y Daily)
Historical charts are for educational visualization only. Drag or pinch to inspect historical candles
Open
73.04
Prev. Close
73.08
Day High
74.27
Day Low
73.00
52-Week High
145.51
52-Week Low
68.77
Session Volume
389.6K
30D Volatility (HV)
22.3%
ZTS Relative Strength Index (RSI 14) Neutral Zone (30-70)
56.86
0 (Oversold <30) 50 (Neutral) 100 (Overbought >70)
ZTS MACD (12, 26, 9) Level Daily Oscillator
-0.556
Signal Line (9)
-1.005
MACD Histogram
+0.448
Volume & Price Highlights APP Fibonacci Pivot Points APP Chart Pattern Detector APP

Market Ranges & Volume

Volume (Vs History) 2.4M
29.9M
Daily Range 73.00
74.27
52-Week Range 68.77
145.51
Quantitative Technical Ratings & AI Signals (ZTS) PREMIUM / ULTRA IN APP
Metric / IndicatorCurrent ReadingAI Action Verdict
RSI (14) Relative Strength 56.86 🔒 Unlock AI Verdict
MACD (12, 26, 9) Level / Signal -0.556 / -1.005 🔒 Unlock AI Verdict
Bollinger Bands (20, 2) & EMA (50/200) 71.16 - 77.08 BULLISH TREND
AI News Sentiment & Momentum Score 82.5 / 100 High Accumulation
AI Hybrid Probability & 30D Target Range 69.67 - 83.01 STRONG BUY

Unlock Full AI Analysis & Statistical Projections for ZTS

You are viewing raw mathematical RSI (56.9) and MACD (-0.556) computations. To unlock AI interpretation, Bullish/Bearish ratings, Bollinger Bands, Executive Insider Trades, and 30-Day Statistical Trend Charts for Zoetis, download the TradeGPT Android app.

Google Play Download on Google Play

About Zoetis (ZTS)

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Read more

Latest ZTS HeadlinesAI Sentiment Scored

Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow - ChartMill
ChartMill • Oct 09, 2026
Sentiment in App
Zoetis (ZTS) Gets A Fresh Heartworm Boost While Fair Value Stays In Focus - Simply Wall Street
Simply Wall Street • Oct 09, 2026
Sentiment in App
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch • Oct 08, 2026
Sentiment in App
A December 1 payout is set as Zoetis (ZTS) declares its fourth-quarter dividend. - Stock Titan
Stock Titan • Oct 08, 2026
Sentiment in App

Related Instruments

XTZUSD
Tezos
ONEQ
ONEQ
EURNZD
EUR/NZD
ICPUSD
Internet Computer
KASUSD
Kaspa